Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone

Published:2013-12 Issue:8 Volume:39 Page:966-973
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Pia Anna,Vignani Francesca,Attard Gerhardt,Tucci Marcello,Bironzo Paolo,Scagliotti Giorgio,Arlt Wiebke,Terzolo Massimo,Berruti Alfredo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference52 articles.

1. The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature;Sonpavde;Eur Urol,2011

2. Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer;Attard;J Clin Endocrinol Metab,2012

3. Genetics of congenital adrenal hyperplasia;Krone;Best Pract Res Clin Endocrinol Metab,2009

4. Abiraterone and increased survival in metastatic prostate cancer;De Bono;N Engl J Med,2011

5. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino polycarboxylic acids-modified abiraterone derivatives as potential injectable anti-prostate cancer agents;Bioorganic Chemistry;2024-09

2. Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer;Annals of Pharmacotherapy;2024-02-12

3. Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTs;Clinical Genitourinary Cancer;2023-10

4. Ascending Flaccid Paralysis Secondary to Hypokalemia in A Cancer Patient using Abiraterone - A Case Report;Current Drug Safety;2023-02

5. Syndromes of Pseudo-Hyperaldosteronism;Clinical Journal of the American Society of Nephrology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3